Real-world Evidence (RWE): A Challenge for Regulatory Agencies Discussion of the RWE Conference with the Network of the European Medicine Agencies, Patients, and Experts

Overview

Journal Front Pharmacol

Date 2022 Aug 12

PMID 35959441

Authors

Patrick Maison

Mahmoud Zureik

Virginie Hivert

Jesper Kjaer

Roman Hossein Khonsari

Gianluca Trifiro

Christelle Ratignier-Carbonneil

Affiliations

Soon will be listed here.

Citing Articles

Patient and Public Involvement in Pharmacoepidemiological Research: An Environmental Scan of an Emerging Area.

Julie R, Yael B, Anais H, Anne T, Julie H, Marie V Pharmacoepidemiol Drug Saf. 2025; 34(1):e70080.

PMID: 39776060 PMC: 11706696. DOI: 10.1002/pds.70080.

Using real-world evidence data and digital monitoring to analyze the hepatotoxic profiles of biologics across more than two million patients.

Banerjee P, Preissner S, Preissner R Sci Rep. 2023; 13(1):10878.

PMID: 37407661 PMC: 10322819. DOI: 10.1038/s41598-023-37979-0.

References

Eichler H, Pignatti F, Schwarzer-Daum B, Hidalgo-Simon A, Eichler I, Arlett P . Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth. Clin Pharmacol Ther. 2020; 109(5):1212-1218. PMC: 8246742. DOI: 10.1002/cpt.2083. View

Chodankar D . Introduction to real-world evidence studies. Perspect Clin Res. 2021; 12(3):171-174. PMC: 8323556. DOI: 10.4103/picr.picr_62_21. View

Flynn R, Plueschke K, Quinten C, Strassmann V, Duijnhoven R, Gordillo-Maranon M . Marketing Authorization Applications Made to the European Medicines Agency in 2018-2019: What was the Contribution of Real-World Evidence?. Clin Pharmacol Ther. 2021; 111(1):90-97. PMC: 9299056. DOI: 10.1002/cpt.2461. View

Eskola S, Leufkens H, Bate A, De Bruin M, Gardarsdottir H . Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018-2019. Clin Pharmacol Ther. 2021; 111(1):310-320. PMC: 9299055. DOI: 10.1002/cpt.2462. View

Jabagi M, Botton J, Bertrand M, Weill A, Farrington P, Zureik M . Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. 2021; 327(1):80-82. PMC: 8609457. DOI: 10.1001/jama.2021.21699. View

Horgan D, Borisch B, Cattaneo I, Caulfield M, Chiti A, Chomienne C . Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare. Int J Environ Res Public Health. 2022; 19(3). PMC: 8835047. DOI: 10.3390/ijerph19031674. View

Purpura C, Garry E, Honig N, Case A, Rassen J . The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications. Clin Pharmacol Ther. 2021; 111(1):135-144. PMC: 9299054. DOI: 10.1002/cpt.2474. View

Corrigan-Curay J, Sacks L, Woodcock J . Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness. JAMA. 2018; 320(9):867-868. DOI: 10.1001/jama.2018.10136. View

Li M, Chen S, Lai Y, Liang Z, Wang J, Shi J . Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model. Front Med (Lausanne). 2021; 8:669509. PMC: 8200400. DOI: 10.3389/fmed.2021.669509. View

10.

Lasky T, McMahon A, Hua W, Forshee R . Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review. Vaccine. 2021; 39(29):3814-3824. PMC: 8500552. DOI: 10.1016/j.vaccine.2021.05.071. View

11.

Courbier S, Dimond R, Bros-Facer V . Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection - quantitative survey and recommendations. Orphanet J Rare Dis. 2019; 14(1):175. PMC: 6625078. DOI: 10.1186/s13023-019-1123-4. View

12.

Dreyer N . Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable. Ther Innov Regul Sci. 2018; 52(3):362-368. PMC: 5944086. DOI: 10.1177/2168479018763591. View

13.

Botton J, Semenzato L, Jabagi M, Baricault B, Weill A, Dray-Spira R . Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations. JAMA Netw Open. 2022; 5(3):e220868. PMC: 8892225. DOI: 10.1001/jamanetworkopen.2022.0868. View

14.

Benkebil M, Gautier S, Gras-Champel V, Massy N, Micallef J, Valnet Rabier M . COVID-19 vaccines surveillance in France: a global response to a major national challenge. Anaesth Crit Care Pain Med. 2021; 40(3):100866. PMC: 8061787. DOI: 10.1016/j.accpm.2021.100866. View

15.

Slattery J, Kurz X . Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?. Pharmacoepidemiol Drug Saf. 2020; 29(10):1336-1340. PMC: 7687174. DOI: 10.1002/pds.5005. View